| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Research Articles: Targets
Interleukin-12-deficient mice are at greater risk of UV radiation–induced skin tumors and malignant transformation of papillomas to carcinomas
1 Department of Dermatology, 2 Skin Diseases Research Center, 3 Biostatistics and Bioinformatics Unit, and 4 Comprehensive Cancer Center, University of Alabama at Birmingham; and 5 Birmingham VA Medical Center, Birmingham, Alabama
Requests for reprints: Santosh K. Katiyar, Department of Dermatology, University of Alabama at Birmingham, 1670 University Boulevard, Volker Hall 557, P.O. Box 202, Birmingham, AL 35294. Phone: 205-975-2608; Fax: 205-934-5745. E-mail: skatiyar{at}uab.edu
Abstract
Solar UV radiation–induced immunosuppression is a risk factor for nonmelanoma skin cancer. Interleukin (IL)-12 has been shown to possess antitumor activity and inhibit the immunosuppressive effects of UV radiation in mice. In this study, we generated IL-12 knockout (KO) mice on a C3H/HeN background to characterize the role of IL-12 in photocarcinogenesis. After exposure of the mice to UVB (180 mJ/cm2) radiation thrice a week for 35 weeks, the development of UV-induced tumors was more rapid and the tumor multiplicity and tumor size were significantly higher in IL-12 KO mice than their wild-type (WT) counterparts (P < 0.05-0.001). Moreover, the malignant transformation of UVB-induced papillomas to carcinomas was higher in IL-12 KO mice in terms of carcinoma incidence (55%, P < 0.001), carcinoma multiplicity (77%, P < 0.001), and carcinoma size (81%, P < 0.001). As IL-12 has the ability to repair UV-induced DNA damage, we determined this effect in our in vivo IL-12 KO mouse model. We found that UVB-induced DNA damage in the form of cyclobutane pyrimidine dimers was removed or repaired more rapidly in WT mice than IL-12 KO mice. Similarly, the UVB-induced sunburn cell formation is primarily a consequence of DNA damage. It was observed that UVB-induced sunburn cells were repaired rapidly in WT mice compared with IL-12 KO mice. The rapid removal or repair of UV-induced cyclobutane pyrimidine dimers or sunburn cells will result in reduced risk of photocarcinogenesis. Taken together, our data show that IL-12 deficiency is associated with the greater risk of photocarcinogenesis in mice, and this may be due to reduction in damaged DNA repair ability. [Mol Cancer Ther 2006;5(4):825–32]
Introduction
Solar UV radiation, particularly UVB (290–320 nm) radiation, is primarily responsible for the high incidence of melanoma and nonmelanoma skin cancers (1, 2). UV radiation has been shown to induce immunosuppression and the UV-induced immunosuppression is considered to be a risk factor for cancer induction (3, 4). Exposure of murine skin to UV radiation suppresses the development of allergic contact hypersensitivity, a prototypic T cell–mediated immune response (5). We have shown that treatment of mice with either a topical application of green tea polyphenols or dietary administration of grape seed proanthocyanidins prevents UV-induced skin carcinogenesis (6, 7) and that, in both cases, the prevention of skin carcinogenesis was associated with the prevention of UVB-induced suppression of the contact hypersensitivity response to a contact sensitizer, 2,4-dinitrofluorobenzene (8–10). Notably, the prevention of the UVB-induced suppression of the contact hypersensitivity response was associated with enhancement of the levels of interleukin (IL)-12 in treated mice compared with untreated mice on exposure to UV, suggesting that IL-12 plays a key role in the effects of these natural products in the prevention of UVB-induced suppression of contact hypersensitivity and UV-induced skin cancer (6, 7, 9, 10).
IL-12 has been previously shown to possess potent antitumor activity in a wide variety of murine tumor models (11–15) of various histologies, including carcinomas from the colon, kidney, and lung (11, 16–19), with the presence of IL-12 at the tumor site being critical for tumor regression (11). Conversely, it has also been shown that the tumor-bearing state is often characterized by a diminished capacity to produce IL-12 and an increase in IL-10 (20). The demonstration of significant antitumor activity in several preclinical animal tumor models has stimulated interest in the therapeutic use of IL-12 (21–23) but the mechanisms underlying the antitumor activity of IL-12 are only incompletely understood.
Solar UV radiation has both the immunosuppressive effect on the immune system as well as carcinogenic effects on the skin (3, 4, 24). UV-induced DNA damage, predominantly in the form of cyclobutane pyrimidine dimers (CPD), has been recognized as an important molecular trigger for the suppression of immune responses (25) and initiation of UV carcinogenesis (25–27). Reduction of CPDs through application of DNA repair enzymes prevents the risk of UV-induced skin cancer (27). It has been observed that IL-12 exhibits the capacity to remove or repair UV-induced DNA damage (28). Depending on the severity of the DNA damage following UV exposure of the skin, keratinocytes in the skin could progress to either apoptosis or DNA repair (29, 30) pathways. If the DNA damage is irreparable, the keratinocyte cell cycle is arrested and it is transformed into a sunburn cell, an initial morphologic indicator of epidermal cell apoptosis. Based on the information that IL-12 possesses an antitumor activity and augment immune responses, we generated IL-12 knockout (KO) mice on a C3H/HeN background to characterize the role of IL-12 in UV radiation–induced skin carcinogenesis. By using IL-12 KO mice and their wild-type (WT) counterparts as a tool, we determined what role IL-12 has in UV-induced skin carcinogenesis.
Materials and Methods
Animals
IL-12 KO mice were generated and bred in our Animal Resource Facility at the University of Alabama at Birmingham. Briefly, male IL-12 (–/–) KO mice on a C57BL/6J genetic background and female C3H/HeN mice (6–7 weeks old) were purchased from The Jackson Laboratory (Bar Harbor, ME). Male IL-12 (–/–) and female C3H/HeN mice were mated to obtain IL-12 (+/–) mice. We then mated male IL-12 (–/–) mice with IL-12 (+/–) female or IL-12 (+/–) males with IL-12 (+/–) females and the progeny was genotyped using a new rapid method of backcrossing for the generation of IL-12 KO mice onto a C3H/HeN mice background. The Transgenic Animal Core Facility of the University of Alabama at Birmingham provided marker-assisted mouse genome scanning, genetic monitoring of the mouse strains, and the accelerated development of congenic mice (31). The IL-12 (–/–) mice carry a germline disruption of the gene. This mutation removes p35 chain of IL-12 protein molecule and therefore completely eliminates the synthesis of IL-12 protein. Mice that are homozygous for this IL-12 deletion mutation are viable but their viability is reduced compared with their WT counterparts (C3H/HeN).
Determination of IL-12 Genotype
The IL-12 genotype of the mice, including confirmation of the genotype of the mice used in the experiments, was determined using PCR analysis of chromosomal DNA extractions from the tail tissues using a standard protocol (32). The PCR protocol was used from The Jackson Laboratory with two pairs of primers in the same reaction. The DNA fragment (280 bp) from the bacterial neomycin resistance gene insert was amplified with 5'-CTTGGGTGGAGAGGCTATTC-3' and 5'-AGGTGAGATGACAGGAGATC-3', whereas the DNA fragment (680 bp) from the IL-12 gene was amplified with 5'-AGTGAACCTCACCTGTGACACG-3' and 5'-TCTTTGCACCAGCCATGAGC-3'. The PCR product from the IL-12 (–/–) homozygote is 280 bp, the PCR product from the IL-12 (+/–) heterozygote is 680 and 280 bp, and the PCR product from the IL-12 (+/+) WT mouse (C3H/HeN) is 680 bp.
The purchased WT mice (C3H/HeN) were acclimatized for at least 1 week before the start of experiments. All mice were maintained in our Animal Resource Facility under the following conditions: 12 hours dark/12 hours light cycle, 24 ± 2°C temperature, and 50 ± 10% relative humidity. The mice were fed Purina Taklad diet (Harlan Teklad, Madison, WI) with water ad libitum. The experimental animal protocols were approved by Institutional Animal Care and Use Committee of the University of Alabama at Birmingham.
UVB Exposure of Mice
At least 48 hours before UVB exposure, the backs of the mice were shaved with electric clippers and treated with Nair depilatory lotion. The groups of mice that were not exposed to UVB were also shaved and depilatory lotion was applied to maintain a similar treatment protocol. UVB irradiation was done as described earlier (6, 7). Briefly, the clipper-shaved and chemically depilated dorsal skin was exposed to UV radiation from a band of four FS20 UVB lamps (Daavlin, UVA/UVB Research Irradiation Unit, Bryan, OH) equipped with an electronic controller to regulate UV dosage. The UV lamps emit UVB (280–320 nm; 
80% of total energy) and UVA (320–375 nm; 20% of total energy), with very little UVC emission (<1%). The majority of the resulting wavelengths of UV radiation are in the UVB range (290–320 nm) with peak emission at 314 nm as monitored (6). The UVB emission was also monitored with an IL-1700 phototherapy radiometer (International Light, Newburyport, MA).
Photocarcinogenesis Protocol
The female mice, 6 to 8 weeks old, were divided into the different treatment groups with 20 mice in each group. The control groups of mice were age- and sex-matched to the experimental group. A long-term photocarcinogenesis protocol was used as described previously (6, 7) in which mice were irradiated daily with UVB (180 mJ/cm2) as described above for a total of 10 days to stimulate tumor initiation (the tumor initiation stage). One week after the last UV exposure of this tumor-initiation stage, the mice were again irradiated with the same dose of UVB thrice weekly (tumor promotion stage) until the end of the protocol. The UVB-irradiated backs of the mice were examined on a weekly basis for papillomas or tumor development. Growths >1 mm in diameter that persisted for at least for 2 weeks were defined as tumors and were recorded. Tumor data for each mouse were recorded until the yield and size stabilized.
Malignant Conversion of Papillomas to Carcinomas
To determine whether the IL-12 KO mice are susceptible to malignant progression of papillomas to carcinomas compared with their WT counterparts, the mice were observed for 35 weeks following the photocarcinogenesis protocol. Carcinoma development was identified grossly as the number of downward invading lesions per mouse per week and each lesion was verified histopathologically at the time of termination of the experiment at 35 weeks (33, 34) or on sacrifice of mice that became moribund before the termination of the experiment. At the termination of the experiment or on sacrifice of moribund mice, the dimensions of all the tumors or carcinomas on each mouse were recorded, and all tumors and suspected carcinomas were harvested for histologic verification. The percentage malignant conversion of benign skin papillomas into squamous cell carcinomas was calculated by dividing the total number of carcinomas by the total number of papillomas and multiplied by 100 (35). Tumor or carcinoma volumes were calculated using the hemiellipsoid model formula: tumor volume = 1/2 (4
/3) (l/2) (w/2) h, where l is length, w is width, and h is height, as described earlier (7).
Histologic Evaluation and Analysis of Tumor Type
The tumors, carcinomas, or suspected carcinomas were processed for histologic evaluation following preparation of conventional paraffin sections (5 µm thick) and H&E staining. The specimens were classified as being actinic keratoses, keratoacanthomas, squamous cell papillomas, or squamous cell carcinomas in a blinded manner by certified pathologists.
Immunohistochemical Detection of CPDs
To detect UVB-induced CPD+ cells in the skin samples, immunostaining was done using a procedure described previously (36). Briefly, frozen skin or lymph node sections (5 µm thick) were thawed and kept in 70 mmol/L NaOH in 70% ethanol for 2 minutes to denature nuclear DNA, followed by neutralization for 1 minute in 100 mmol/L Tris-HCl (pH 7.5) in 70% ethanol. Slides were washed with PBS and then incubated for 30 minutes with 10% goat serum in PBS. Sections were then incubated with thymine dimer–specific monoclonal antibody (Kamiya Biomedical Company, Seattle, WA) or an isotype control antibody (IgG1). Bound anti-CPD antibody was detected by incubation with biotinylated goat anti-mouse IgG1 followed by peroxidase-labeled streptavidin. Sections were then incubated with diaminobenzidine plus peroxidase substrate for 5 minutes. The sections were rinsed with distilled water and counterstained with H&E.
Dot-Blot Analysis
Genomic DNA from the epidermis was isolated following the standard procedures (32). Genomic DNA (500 ng) was transferred to a positively charged nitrocellulose membrane by vacuum dot-blotting (Bio-Dot Apparatus, Bio-Rad, Hercules, CA) and fixed by baking the membrane for 30 minutes at 80°C. After blocking the nonspecific binding sites in blocking buffer [5% nonfat dry milk, 1% Tween 20 in 20 mmol/L TBS (pH 7.6)], the membrane was then incubated with the antibody specific to CPDs for 1 hour at room temperature. After washing in washing buffer, the membrane was again incubated with horseradish peroxidase–conjugated secondary antibody. The CPDs containing DNA was detected by chemiluminescence using an enhanced chemiluminescence detection system. The experiments were repeated thrice.
Detection of Sunburn Cells
IL-12 KO as well as WT mice were exposed to UVB (60 mJ/cm2). Mice were sacrificed later at indicated times, and the skin samples at least 1 cm long were obtained, fixed in formaldehyde, and embedded in paraffin. Tissue sections (5 µm) were stained with H&E. Sunburn cells were identified and counted throughout the epidermis of the section using light microscopy. Identification of apoptotic sunburn cell was based morphologically on cell membrane shrinkage and nuclear condensation attributable to fragmentation of the cells (30, 37). The percentage of apoptotic sunburn cells in the epidermis was calculated from the number of these cells / 100 cells counted from the entire 1 cm length of the epidermis for each skin section (n = 5).
Statistical Analysis
The susceptibility of IL-12 KO mice to tumors and carcinomas caused by UVB radiation was compared with the susceptibility of WT, C3H/HeN, mice. The four outcome variables used in this comparison were tumor incidence, tumor multiplicity, carcinoma incidence, and carcinoma multiplicity. The data were collected in an aggregate form over a period of 35 weeks. A linear model was fit to each of the outcome variables. The independent variables in the model were group, time, and a group/time interaction term. The interaction term helps to test if the rate of change in the outcome variables over time is a function of the group. To compare the numbers of CPD+ cells or sunburn cells in different treatment groups, at least five to six different fields from each section were selected. A simple ANOVA followed by an appropriate post hoc test was used to calculate statistical significance of the data obtained from tumor volume, immunostaining of CPD+ cells, dot-blot analysis, or sunburn cells. P < 0.05 was considered significant.
Results
IL-12-Deficient (KO) Mice Are Susceptible to UVB-Induced Skin Carcinogenesis
As IL-12 has been shown to possess antitumor activity (11, 12, 16), we determined the effect of IL-12 deficiency on susceptibility to UVB-induced skin carcinogenesis. On exposure to a standard photocarcinogenesis protocol, we found that UVB-induced tumor development occurred 14 days earlier in IL-12 KO mice than their WT counterparts (Fig. 1
). Throughout the photocarcinogenesis protocol, the percentage of IL-12 KO mice with tumors was higher than the percentage of WT mice with tumors. This effect persisted through the termination of the experiment but did not attain statistical significance under the conditions used in this study (Fig. 1A). In terms of tumor multiplicity, the total number of tumors in the group of IL-12 KO mice remained higher than the total number in the group of WT mice throughout the experimental protocol (Fig. 1B). At the termination of the experiment, the total number of tumors was significantly higher in the group of IL-12 KO mice than the group of WT mice (72 versus. 42, P < 0.01). Similarly, in terms of tumors per tumor-bearing mouse, a higher number of tumors per tumor-bearing mouse was observed throughout the experiment in the group of IL-12 KO mice than in the group of WT mice (Fig. 1C) and was significantly higher at the termination of the experiment (P < 0.05). At the termination of the experiment, the tumor volume of each mouse in each group was measured (Fig. 1D), and it was observed that tumor volume per tumor was significantly higher in the group of IL-12 KO mice compared with their WTs (P < 0.001). Taken together, these data concerning incidence and size of the UV-induced tumors clearly indicate that IL-12-deficient mice are extremely susceptible to UVB-induced carcinogenesis.
|
|
2-fold; P < 0.01; Fig. 2D) than in WT mice. Interestingly, we noted that the carcinomas that developed in the IL-12 KO mice tended to occur in clusters of three to four and that this clustering tendency was not apparent in the WT mice. These data clearly indicate that not only are IL-12-deficient mice extremely susceptible to UV-induced carcinogenesis, but they are extremely susceptible to progression of papillomas to carcinomas.
|
|
|
|
The photocarcinogenesis experiments conducted in IL-12 KO and their WT mice (C3H/HeN) indicated that IL-12 KO mice are at a greater risk of UVB radiation–induced skin carcinogenesis in terms of tumor incidence, tumor multiplicity, and the growth of the developing tumors than their WT counterparts (Fig. 1). Additionally, the present study also establishes that mice that are deficient in IL-12 are at greater risk of malignant progression of papillomas to carcinomas (Fig. 2). These data clearly provide an indication that IL-12 plays a preventive role in UV-induced skin carcinogenesis, and are in concordance with the results of other studies in which IL-12 has been shown to cure or improve the survival of tumor-bearing mice in several other tumor models (11, 16–19).
It has been recognized that UV-induced immunosuppression is a risk factor in the development of UV radiation–induced skin carcinogenesis (3, 4), and that IL-12 has the capability to reverse the UVB-induced suppression of immune responses, at least in mice (38–40). Therefore, the data obtained from our genetically modified mouse model, where IL-12 KO mice and their WTs were used, clearly indicates that immunoregulatory cytokine IL-12 may have a role in prevention of UVB-induced skin carcinogenesis.
It has been shown that UVB-induced DNA damage in the form of CPDs has a role in immunosuppression and initiation of photocarcinogenesis. IL-12 has the ability to remove or repair UVB-induced CPDs and can reverse the UVB-induced immunosuppression (28, 38, 40). Therefore, we determined whether there is any difference in repair kinetics of UVB-induced CPDs in between IL-12 KO and their WT mice. Our observations that WT mice after UV irradiation removes or repairs UV-induced CPDs faster than IL-12 KO mice indicates the susceptibility of IL-12 KO mice toward photocarcinogenesis compared with their WT counterparts. Moreover, the s.c. injection of recombinant IL-12 to UV-irradiated mouse skin in IL-12 KO mice enhanced the repair of UVB-induced CPDs compared with non–recombinant IL-12-treated, UVB-exposed IL-12 KO mice. This effect in IL-12 KO mice was similar to WT mice. These data further support that the deficiency of IL-12 in mice may stimulate the susceptibility for photocarcinogenesis.
Induction of apoptosis is an additional protective mechanism as it eliminates cells that were unable to repair UVB-induced DNA damage completely (41). Therefore, dysregulation of UV-induced apoptosis will enhance the risk of photocarcinogenesis. There are several ways to inhibit UVB-induced apoptosis, such as overexpression of heat-shock proteins (42), induction of antiapoptotic proteins (43), and disruption of p53 function (30), etc. As these events allow the survival of cells carrying DNA damage, they may give rise to mutations and skin cancer development. Here, we provide the evidence that UVB-induced sunburn cells were repaired or removed rapidly in WT mice when determined at different time points after UV irradiation of the skin (Fig. 5). In contrast, this effect was not seen in IL-12 KO mice (Fig. 5). However, the treatment of IL-12 in in vivo IL-12 KO mice has resulted in a rapid removal or repair of UVB-induced sunburn cell compared with non–recombinant IL-12-treated, IL-12 KO mice, and this effect of recombinant IL-12 injection was similar to that found in WT mice. The fact that there was no significant difference in the amount of DNA damage immediately after UVB irradiation (Figs. 3–5) but a difference at a later time point can only be explained by enhanced removal or repair of damaged DNA lesions. These data confirms that the DNA repair mechanism in WT mice is faster than IL-12 KO mice and that may be mediated through the presence of IL-12.
The data obtained in this study clearly indicate that IL-12 deficiency is a risk factor for photocarcinogenesis in mice. It is tempting to suggest that IL-12 may have a role in prevention of photocarcinogenesis and therefore use of those natural products (whether through topical or dietary), which can induce the IL-12 induction in vivo or IL-12 therapy, may help to reduce the risk of UV radiation–induced skin cancers in humans.
Footnotes
Grant support: Veterans Administration Merit Review Award (S.K. Katiyar), National Center for Complementary and Alternative Medicine, NIH, grant 1 RO1 AT002536 (S.K. Katiyar), and University of Alabama Skin Diseases Research Center grant AR050948-01.
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Received 1/ 3/06; revised 1/27/06; accepted 2/16/06.
References
production by anti-tumor T cells. Int Immunol 1995;7:1135–45. production. J Immunol 1994;153:1697–706.[Abstract] Wigginton JM, Komschlies KL, Back TC, Franco JL, Brunda MJ, Wiltrout RH. Administration of interleukin 12 with pulse interleukin 2 and the rapid and complete eradication of murine renal carcinoma. J Natl Cancer Inst 1996;88:38–43.This article has been cited by other articles:
|
|
 |
|
  S. M. Meeran, S. Katiyar, C. A. Elmets, and S. K. Katiyar Interleukin-12 Deficiency Is Permissive for Angiogenesis in UV Radiation-Induced Skin Tumors Cancer Res., April 15, 2007; 67(8): 3785 - 3793. [Abstract] [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
